Ladone Mary Kay — SEC insider filings
SEC reporting owner CIK 1760737. 30 insider filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2020-11-05 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 5 filings — 26,254 shares, $3,022,461 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 81.
- Largest priced transaction: sale of 6,000 shares @ $120.00 ($720,000) in Hill-Rom Holdings, Inc., filed 2021-07-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Hill-Rom Holdings, Inc. (HRC) | SVP, Corp. Dev., Strat. & IR | 9 | — | 10 legs · 22,346 sh · $2,923,996 | 46 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Director | 2 | — | 1 leg · 3,908 sh · $98,464 | 2 |
| Bioventus Inc. (BVS) | Director | 9 | — | — | 20 |
| NOVANTA INC (NOVT) | Director | 4 | — | — | 7 |
| Inogen Inc (INGN) | Director | 6 | — | — | 6 |
Insider filings — Ladone Mary Kay
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Sale (S): 3,908 @ $25.20 · Grant/award (A): 7,217 | EDGAR |
| 2026-06-09 | 4 | Inogen Inc (INGN) | Grant/award (A): 28,081 @ $0 | EDGAR |
| 2026-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 32,282 @ $0 · Option exercise (M): 32,282 (derivative) @ $0 · Grant/award (A): 25,146 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | NOVANTA INC (NOVT) | Option exercise (M): 1,325 · Option exercise (M): 1,325 (derivative) · Grant/award (A): 1,799 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Grant/award (A): 10,909 | EDGAR |
| 2025-07-14 | 4 | NOVANTA INC (NOVT) | Option exercise (M): 572 · Option exercise (M): 572 (derivative) | EDGAR |
| 2025-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 32,282 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Inogen Inc (INGN) | Grant/award (A): 30,612 @ $0 | EDGAR |
| 2025-01-06 | 4 | NOVANTA INC (NOVT) | Grant/award (A): 1,325 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | NOVANTA INC (NOVT) | Grant/award (A): 572 (derivative) | EDGAR |
| 2024-06-18 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 1,814 @ $0 · Option exercise (M): 1,814 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 26,493 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Inogen Inc (INGN) | Grant/award (A): 21,871 @ $0 | EDGAR |
| 2023-06-20 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 1,813 @ $0 · Option exercise (M): 1,813 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 16,648 @ $0 · Option exercise (M): 16,648 (derivative) @ $0 · Grant/award (A): 30,400 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | Inogen Inc (INGN) | Grant/award (A): 17,094 @ $0 | EDGAR |
| 2022-06-22 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 1,813 @ $0 · Option exercise (M): 1,813 (derivative) @ $0 · Grant/award (A): 16,648 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Inogen Inc (INGN) | Grant/award (A): 6,849 @ $0 | EDGAR |
| 2022-03-24 | 4 | Inogen Inc (INGN) | Grant/award (A): 459 @ $0 | EDGAR |
| 2021-12-15 | 4 | Hill-Rom Holdings, Inc. (HRC) | Disposition to issuer (D): 2,284 · Disposition to issuer (D): 4,102 (derivative) @ $52.89 · Disposition to issuer (D): 6,054 (derivative) @ $61.86 · Disposition to issuer (D): 3,947 (derivative) · Disposition to issuer (D): 4,092 (derivative) · Disposition to issuer (D): 664 (derivative) · +2 more | EDGAR |
| 2021-11-16 | 4 | Hill-Rom Holdings, Inc. (HRC) | Option exercise (M): 700 · Tax withholding (F): 253 @ $155.11 · Option exercise (M): 700 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Hill-Rom Holdings, Inc. (HRC) | Option exercise (M): 2,018 @ $94.14 · Sale (S): 2,018 @ $155.14 · Grant/award (A): 6,708 (derivative) @ $0 · Option exercise (M): 2,018 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Hill-Rom Holdings, Inc. (HRC) | Option exercise (M): 872 @ $78.16 · Sale (S): 872 @ $155.08 · Option exercise (M): 2,051 @ $103.11 · Sale (S): 2,051 @ $155.08 · Option exercise (M): 1,937 · Tax withholding (F): 568 @ $155.09 · +6 more | EDGAR |
| 2021-07-30 | 4 | Hill-Rom Holdings, Inc. (HRC) | Sale (S): 3,000 @ $125 · Sale (S): 2,698 @ $130 · Option exercise (M): 1,307 @ $78.16 · Sale (S): 1,307 @ $125 · Option exercise (M): 2,051 @ $103.11 · Sale (S): 2,051 @ $130 · +2 more | EDGAR |
| 2021-07-27 | 4 | Hill-Rom Holdings, Inc. (HRC) | Sale (S): 6,000 @ $120 · Option exercise (M): 1,042 @ $53.70 · Sale (S): 1,042 @ $120 · Option exercise (M): 1,307 @ $78.16 · Sale (S): 1,307 @ $120 · Option exercise (M): 1,042 (derivative) @ $53.70 · +1 more | EDGAR |
| 2021-07-19 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 5,440 (derivative) @ $0 | EDGAR |
| 2020-11-13 | 4 | Hill-Rom Holdings, Inc. (HRC) | Grant/award (A): 2,046 (derivative) @ $0 · Grant/award (A): 8,072 (derivative) @ $0 | EDGAR |
| 2020-11-10 | 4 | Hill-Rom Holdings, Inc. (HRC) | Option exercise (M): 991 @ $95.75 · Tax withholding (F): 291 @ $95.75 · Option exercise (M): 1,919 @ $95.75 · Tax withholding (F): 563 @ $95.75 · Option exercise (M): 676 @ $95.75 · Tax withholding (F): 199 @ $95.75 · +3 more | EDGAR |
| 2020-11-05 | 4 | Hill-Rom Holdings, Inc. (HRC) | Option exercise (M): 1,418 @ $91.54 · Tax withholding (F): 416 @ $91.54 · Option exercise (M): 1,418 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1760737 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs